European Commission (EC) has granted marketing authorisation for Nplate(R) (romiplostim)
- Details
- Category: Amgen

European Commission Clears Acquisition of Zentiva NV by sanofi-aventis
- Details
- Category: Sanofi

Strong operating results for Roche in 2008
- Details
- Category: Roche

Roche Announces Interim Results from a Phase III ATLAS Study
- Details
- Category: Roche

Lipitor Significantly Reduced hsCRP Levels in Patients with Stable Coronary Artery Disease
- Details
- Category: Pfizer

Novartis increases dividend by 25% based on strong 2008 results
- Details
- Category: Novartis

Pfizer Discontinues Global Phase III Trial of Axitinib
- Details
- Category: Pfizer

More Pharma News ...
- AstraZeneca PLC Fourth Quarter and Full Year Results 2008
- Strong Fourth Quarter Supports Excellent 2008 for Bristol-Myers Squibb
- GSK to drive growth in emerging markets with acquisition of UCB products
- Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
- Novartis launches Extavia®, the standard-of-care for relapsing forms of multiple sclerosis
- Foundation-laying ceremony for new R&D building at Roche Basel
- Amgen's Breakaway from Cancer Initiative Expands to Help Cancer Patients